Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Innovative Tributyrin Supplement Viscera-3® to Promote Natural Bloating and Gas Relief And Support Overall Health Now Available For Purchase on Amazon


News provided by

SANESolution

Nov 18, 2022, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Today, SANESolution is announcing that their groundbreaking gut health supplement, Viscera-3® with Tributyrin, a clinically researched and patent-pending form of gut-health superstar Butyrate, is now available for purchase on Amazon.

SEATTLE, Nov. 18, 2022 /PRNewswire-PRWeb/ -- Today, SANESolution is announcing that their groundbreaking gut health supplement, Viscera-3® with Tributyrin, a clinically researched and patent-pending form of gut-health superstar Butyrate, is now available for purchase on Amazon.

In the past two decades, scientists have discovered that the gut plays a significant role in long-term health and disease prevention. The cells and bacteria that make up the microbiome of the gut are not only responsible for correct digestion and nutrient absorption, but they also defend against a large number of diseases. Conversely, when the gut microbes are out of balance, a condition known as dysbiosis, it can lead to numerous health issues.

We call it Viscera-3® because by bonding 3 molecules of the POSTBiotic Butyrate with one glycerol molecule, we prevent digestive destruction of the POSTBiotic and deliver the best gut and health support ever documented.

Post this

Matthew Olesiak, M.D., the Chief Medical Director at SANESolution, said, "The earliest and most obvious signs of poor gut health/dysbiosis are gas, bloating, diarrhea, and constipation. Many people depend on anti-gas and bloating pills for relief, but these products, at best, offer only a temporary fix. Therefore, we wanted to create a product that helps to address the underlying cause of dysbiosis, so people may finally experience lasting relief and better health outcomes."

In a quest to make optimal gut health achievable for everyone, Dr. Olesiak and the scientists at SANESolution focused on Butyrate, a POSTbiotic metabolite shown to optimize gut function and provide widespread health benefits in numerous scientific studies. POSTbiotiics are the end product of bacterial fermentation of fiber in the lower colon. But then, Dr. Olesiak and his team made a shocking discovery.

"We found that creating a Butyrate supplement for gut health was impossible because the digestive process destroys POSTbiotic metabolites," said Dr. Olesiak. "From a medical perspective, the 'holy grail' of gut health would be to administer Butyrate directly into the gut. Finding a method to prevent supplemental Butyrate from being destroyed by the digestive system would be the largest breakthrough in gut health in the last century."

Dr. Olesiak and Jonathan Bailor, Founder and CEO of SANESolution, are thrilled to report that they arrived at this gut health 'holy grail' by adding a patent-pending form of Tributyrin to Viscera-3®, making it the first and only synergistic gut-supporting Butyrate formulation to survive digestion and successfully deliver the "optimal" POSTBiotic directly into the gut.

"We call it Viscera-3® because by bonding 3 molecules of the POSTBiotic Butyrate with one glycerol molecule, we prevent digestive destruction of the POSTBiotic and deliver the best gut and health support ever documented," explains Dr. Olesiak.

Recent independent clinical research studies echo Dr. Olesiak's optimism about the following benefits of the POSTBiotic in Visera-3®:

Supports digestive and gastrointestinal health, potentially reducing painful gas and bloating (1, 2)
Supports Reduced intestinal inflammation, which may ease symptoms of inflammatory bowel disease (IBD) (3)
Supports immune health (4)
Soothes inflammation (5)
Support improved brain function (7, 8)
Supports weight loss/weight maintenance by potentially helping to boost metabolism and increasing insulin sensitivity (9)

During his research, Dr. Olesiak discovered four other nutrients also shown to synergistically and naturally support gut health, including magnesium and chromium, which he also included in the formula to create the ultimate supplement for a healthy gut and body.

Backed by this patent-pending molecular innovation, Viscera-3®, is the breakthrough POSTBiotic gut health product of 2022, as it addresses the root cause of digestive issues and supports the gas and bloating relief promised but not delivered by other digestive aids while promoting a healthy body.

Viscera-3® is available for purchase nationwide on Amazon for $19.99 per bottle containing 45 capsules. For more information on Viscera-3® or to purchase it, visit: https://www.amazon.com/Viscera-3-Postbiotics-TRI-Butyrate-Supplement/dp/B08GQF6B15

####
About SANESolution:

SANESolution is a wellness technology and metabolic healing company dedicated to ending the Diabesity (diabetes plus obesity) epidemic. Backed by 1,300 clinical studies and thousands of success stories, SANESolution's metabolic healing framework and model is the only program endorsed by top doctors at the Harvard Medical School, Johns Hopkins, the Mayo Clinic, the Cleveland Clinic, and UCLA, and is the subject of New York Times best-selling books, and award-winning documentaries. Started as a not-for-profit research project by a ten-year Microsoft alum, Jonathan Bailor, SANESolution has transformed into a trusted international wellness brand focused on reversing the most common and devastating modern diseases. Using the latest innovations in biochemical research and a "service-first story-based" marketing approach to reach, lift up, and educate consumer health choices, SANESolution is changing the world of wellness by helping everyone from the underprivileged to the Fortune 500 CEO to regain their "SANEity" one new "SANE" consumer at a time. SANESolution was inducted into Inc. 5000's list of "Fastest-Growing Private Companies in America" for 2020. For more information, visit: https://store.sanesolution.com

SANE Viscera-3™ Ingredients:

Magnesium (as Magnesium Oxide and Magnesium Bisglycinate Chelate)
Chromium (as Chromium Picolinate)
CoreBiome™ Tributyrin
Pomegranate (Punica granatum) Fruit Extract 40%
Ellagic Acid
Grape (Vitis vinifera) Seed Ext 95% Proanthocyandins

Other ingredients: Gelatin (Capsule), Magnesium Stearate, Silicon Dioxide, Cellulose.

Scientific References

1- https://pubmed.ncbi.nlm.nih.gov/24868283/

2- https://pubmed.ncbi.nlm.nih.gov/22738315/

3- https://pubmed.ncbi.nlm.nih.gov/26925050/

4- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816278/

5- https://pubmed.ncbi.nlm.nih.gov/24868283/

6- https://pubmed.ncbi.nlm.nih.gov/23514803/

7- https://pubmed.ncbi.nlm.nih.gov/23514803/

8- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903954/

9- https://pubmed.ncbi.nlm.nih.gov/19366864/

10- https://pubmed.ncbi.nlm.nih.gov/19366864/

Media Contact

SANESolution, [email protected], +1 6469026690, [email protected]

SOURCE SANESolution

Modal title

SANESolution Viscera-3
SANESolution Viscera-3
SANESolution Viscera-3

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.